spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  photodynamic therapy 

 HSMN NewsFeed - 4 May 2023
Soligenix Announces Positive Clinical Results from Compatibility Study of HyBryte(TM) in the Treatment of Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Apr 2023
Soligenix Provides Regulatory Update on HyBryte(TM)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Feb 2023
Soligenix Receives Refusal to File Letter from U.S. FDA for HyBryte(TM) New Drug Application in the Treatment of Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Nov 2021
Kintara Announces Changes to Executive Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Sep 2021
Kintara Reports Topline Results from Phase 2 Clinical Study of VAL-083 as Adjuvant Therapy for Newly-Diagnosed GBM Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Jan 2021
Olympus to Acquire Quest Photonic Devices B.V. to Bolster Surgical Endoscopy Capabilities
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 22 Dec 2020
Soligenix Announces Topline Results from its Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Aug 2020
Kintara Therapeutics (Formerly DelMar Pharmaceuticals) Announces Completion of Merger with Adgero Biopharmaceuticals and Closing of $19.6 Million Private Placement Priced At-The-Market
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 17 Aug 2020
DelMar Announces Approval of Merger by Stockholders
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 15 May 2020
Soligenix Announces Recent Accomplishments And First Quarter 2020 Financial Results
Biopharmaceuticals
 HSMN NewsFeed - 30 Apr 2020
Soligenix Announces Positive Phase 3 FLASH Study Demonstrates Increased Efficacy with Continued Treatment in Patients with Cutaneous T-Cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Sep 2019
Soligenix Appoints Daniel P. Ring as Vice President of Business Development and Strategic Planning
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Sep 2019
Soligenix Appoints Jonathan Guarino as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2019
Soligenix Announces Appointment of Diane L. Parks to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Oct 2018
Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX301 for the Treatment of Cutaneous T-cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Jul 2018
Soligenix Announces Appointment of Mark Pearson to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jun 2018
Steba Biotech's TOOKAD(R) Vascular Photodynamic Therapy Maintains Significant Reduction in Overall Progression and Conversion to Radical Therapy in Low-risk Prostate Cancer Patients at 4 Years
Biopharmaceuticals Urology Oncology
 HSMN NewsFeed - 19 Jun 2017
Complete Efficacy and Long-Term Follow-Up Safety Results from SGX942 Phase 2 Oral Mucositis Clinical Trial to be Presented at the 2017 Multinational Association for Supportive Care in Cancer Conference
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 May 2017
Soligenix Receives FDA Protocol Clearance of Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Oct 2016
FDA Grants Priority Review to Genentech’s Lucentis(R) (Ranibizumab Injection) Supplemental Biologics License Application for Myopic Choroidal Neovascularization
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 12 Sep 2016
Soligenix and SciClone Establish Regional Licensing Agreement for SGX942, a Novel Product Candidate for Oral Mucositis
Biopharmaceuticals Licensing
 HSMN NewsFeed - 25 Jan 2016
Steba Biotech Completes its European Phase 3 Clinical Trial of TOOKAD(R) in Patients with Low-Risk Prostate Cancer and Submits Marketing Authorization Application to the European Medicine Agency
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 3 Aug 2015
Soligenix Enters into a $10 Million Equity Purchase Agreement
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 7 Oct 2014
Pinnacle Biologics, Inc., a subsidiary of Concordia Healthcare Corp., announces European site initiation of Phase 3 bile duct cancer trial using photodynamic therapy with PHOTOFRIN(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Mar 2014
FDA Approves Optiguide(R) DCYL700 Fiber Optic Diffuser Series Flexible Fiber
Devices FDA
 HSMN NewsFeed - 24 Dec 2013
Concordia Healthcare Corp. Announces Acquisition Of Pinnacle Biologics, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 2 Oct 2013
KLOX Technologies Announces Approval in Canada of its Innovative Acne Vulgaris Treatment
Devices Dermatology Regulatory
 HSMN NewsFeed - 8 Nov 2012
Sun Pharma to Acquire DUSA Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Mar 2011
Bausch & Lomb Appoints David Mordaunt, Ph.D. as Vice President, Development and Research, Surgical
Devices Ophthalmology Personnel
 HSMN NewsFeed - 15 Mar 2011
Breakthrough Light-Activated Drug-Device to be Investigated for Treatment of HPV* and Cervical Pre-cancer
Biopharmaceuticals Devices Oncology
 HSMN NewsFeed - 9 Dec 2009
6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 19 Oct 2009
QLT restructures Visudyne(R) agreement
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 15 Jun 2009
QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 11 May 2009
DUSA Initiates Clinical Trial of Levulan(R) PDT on High-Risk Solid Organ Transplant Recipients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Jan 2009
DUSA Elects Alexander Casdin to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2008
PhotoMedex Now Distributing Omnilux Photodynamic Therapy Line by Photo Therapeutics
Devices Dermatology Distribution
 HSMN NewsFeed - 26 Aug 2008
QLT announces agreement to exclusively license the Atrigel(R) Technology to Reckitt Benckiser Pharmaceuticals Inc.
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 18 Jul 2008
DUSA Announces Update on Nicomide(R) Status
Biopharmaceuticals
 HSMN NewsFeed - 21 Apr 2008
DUSA Pharmaceuticals Chairman Role Expected to Change Due to Serious Illness
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Apr 2008
Diomed Holdings Enters into Sale Agreement with AngioDynamics
Devices Acquisitions
 HSMN NewsFeed - 28 Mar 2008
Positive results from Visudyne(R) combination therapy study reported at Annual Macula Society Conference
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 17 Mar 2008
QLT announces positive FDA action on Aczone(TM)
Biopharmaceuticals
 HSMN NewsFeed - 14 Mar 2008
Diomed Files Petition Under Chapter 11 of the U.S. Bankruptcy Code, Seeks Sale of U.S. Business to Biolitec AG
Devices
 HSMN NewsFeed - 22 Jan 2008
Defendant in Diomed Patent Litigation Files for Chapter 11 Protection
Devices Litigation
 HSMN NewsFeed - 18 Jan 2008
QLT reduces workforce as first step in its strategic restructure
Biopharmaceuticals
 HSMN NewsFeed - 16 Jan 2008
Court Rules On Contempt Motion in Diomed Patent Litigation
Devices Interventional Litigation
 HSMN NewsFeed - 14 Jan 2008
Court Sets Hearing Date for Diomed Preliminary Injunction Against Total Vein Solutions
Devices Litigation
 HSMN NewsFeed - 14 Jan 2008
Court Sets June Trial Date in Patent Litigation
Devices Litigation
 HSMN NewsFeed - 14 Jan 2008
Cannasat Therapeutics Appoints Dr. Julia Levy to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2008
Follica Raises $5.5 M To Advance New Treatment for Androgenetic Alopecia Into the Clinic
Devices Dermatology Venture Capital
 HSMN NewsFeed - 10 Dec 2007
Diomed Comments on Status Conference in VNUS Litigation
Devices Litigation
 HSMN NewsFeed - 30 Oct 2007
Diomed Comments on Pretrial Motions in VNUS Litigation
Devices Litigation
 HSMN NewsFeed - 29 Oct 2007
DUSA and River's Edge Announce Settlement Agreement Involving Nicomide(R)
Biopharmaceuticals Litigation
 HSMN NewsFeed - 23 Oct 2007
Diomed Responds to VNUS Patent Litigation Trial Delay and Summary Judgment Motion Ruling
Devices Litigation
 HSMN NewsFeed - 18 Oct 2007
QLT Completes Acquisition of ForSight Newco II, Inc.
Biopharmaceuticals Ophthalmology Drug Delivery
 HSMN NewsFeed - 9 Oct 2007
ForSight Labs Announces Acquisition of ForSight Newco II by QLT, Inc.
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 9 Oct 2007
QLT acquires leading edge ocular drug delivery system from ForSight Labs
Biopharmaceuticals Ophthalmology Drug Delivery
 HSMN NewsFeed - 8 Oct 2007
21st World Congress of Dermatology Highlights Clinical Significance of Photodynamic Therapy
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 3 Oct 2007
Diomed Comments on Summary Judgment Rulings in VNUS Patent Infringement Lawsuit
Devices Litigation
 HSMN NewsFeed - 31 Aug 2007
Eligard(R) six-month formulation successfully completes European approval procedure
Biopharmaceuticals Drug Delivery Regulatory Oncology
 HSMN NewsFeed - 23 Jul 2007
QLT announces FDA filing and review of Aczone(TM) labeling supplement for removal of blood screening requirement
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 12 Jul 2007
Diomed Seeks Preliminary Injunction Against Total Vein Solutions
Devices Litigation
 HSMN NewsFeed - 2 Jul 2007
Judge Grants Diomed Permanent Injunction in '777 Patent Case
Devices Litigation
 HSMN NewsFeed - 14 Jun 2007
DUSA Pharmaceuticals, Inc. Elects Robert F. Doman as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2007
QLT USA, Inc. files Aczone(TM) labeling supplement for removal of blood screening requirement
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 17 May 2007
DUSA Pharmaceuticals Receives Orphan Drug Designation for Levulan(R) PDT to Treat Esophageal Dysplasia
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 May 2007
Quest PharmaTech and Paramount BioSciences Sign Exclusive Multinational License Agreement to Develop and Commercialize SonoLight Technology for Dermatology Applications
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 9 May 2007
Court Sets Injunction Hearing Date in Diomed EVLT Patent Litigation
Devices Litigation
 HSMN NewsFeed - 4 May 2007
Bristol-Myers Squibb Joins Oslo Cancer Cluster
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 May 2007
QLT strengthens its expertise in ocular by adding David A. Saperstein M.D. as interim Chief Medical Officer and Paul L. Kaufman M.D. as Head of the Ocular Scientific Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Apr 2007
QLT announces that CHMP will recommend to the European Commission that occult indication be deleted from the Visudyne(R)label in European Union
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 5 Mar 2007
QLT Settles MEEI Lawsuit With Respect to the '303 Patent
Biopharmaceuticals Ophthalmology Litigation
 HSMN NewsFeed - 23 Jan 2007
DUSA Pharmaceuticals, Inc.: International Guidelines Recommend Photodynamic Therapy as First-Line Treatment for Actinic Keratoses
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 8 Jan 2007
DUSA Pharmaceuticals Announces Exclusive Agreement with Daewoong to Market DUSA's Levulan'R' Kerastick'R' for Photodynamic Therapy in Asian Territories
Biopharmaceuticals Dermatology Licensing Distribution
 HSMN NewsFeed - 8 Dec 2006
Court Sets Trial Date in Diomed EVLT Patent Litigation
Devices Litigation
 HSMN NewsFeed - 1 Dec 2006
Eligard(R) six-month formulation approved in Germany
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Oct 2006
DUSA Pharmaceuticals Reports Brazilian Regulatory Approval for Levulan
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 5 Oct 2006
New Non-Invasive Applications for LED Light Therapy From Photo Therapeutics
Devices Dermatology
 HSMN NewsFeed - 4 Oct 2006
New England Journal of Medicine Publishes Data From Lucentis Pivotal Phase III Studies in Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 11 Sep 2006
Court Rules in Favor of Diomed on Marked EVLT Sheath
Devices Litigation
 HSMN NewsFeed - 3 Aug 2006
BDSI Announces Purchase of Non-U.S. BEMA(TM) Technology from QLT USA, Inc.
Biopharmaceuticals Acquisitions Drug Delivery
 HSMN NewsFeed - 11 Jul 2006
DUSA Pharmaceuticals Sues Additional Physicians and a Chemical Supplier for Infringement of its Levulan'R' Photodynamic Therapy Patents
Biopharmaceuticals Litigation
 HSMN NewsFeed - 30 Jun 2006
FDA Approves LUCENTIS for the Treatment of Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 26 Jun 2006
Lumenis Invests in Exclusive, Worldwide License for New Ophthalmic Technology
Devices Ophthalmology Licensing
 HSMN NewsFeed - 23 Jun 2006
Diomed and Vascular Solutions Settle Trade Secret and Sheath Marking Litigation
Devices Litigation
 HSMN NewsFeed - 21 Jun 2006
DUSA Pharmaceuticals Announces Georgia Court Dismissal of River's Edge Suit
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 15 Jun 2006
DUSA Pharmaceuticals Announces Election of Robert F. Doman to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2006
Preliminary Results from a Phase IIIb Study Showed Patients With Wet AMD Treated With Lucentis Quarterly Experienced a 16-Letter Benefit Over the Control Group at One Year
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 31 May 2006
DUSA Pharmaceuticals And PhotoCure ASA Settle Patent Disputes
Biopharmaceuticals Litigation
 HSMN NewsFeed - 25 May 2006
QLT strengthens corporate development and legal functions with the appointment of Peter J. O'Callaghan as Senior Vice President, Corporate Development and General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 May 2006
Diomed and BSN-JOBST Form Sales & Marketing Alliance
Devices
 HSMN NewsFeed - 15 May 2006
Dusa Pharmaceuticals Announces Court Ruling Halts Sale of Generic Nicomide'R'
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 10 Apr 2006
DUSA Announces Hiring of William F. O'Dell as Executive Vice President, Sales and Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Apr 2006
QLT announces that Court of Appeals grants stay of injunction against Eligard(R) sales
Biopharmaceuticals Litigation
 HSMN NewsFeed - 5 Apr 2006
QLT announces co-development and licensing agreement with Retinagenix for early stage ocular synthetic retinoid program
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 31 Mar 2006
DUSA Pharmaceuticals Reports Lawsuit
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Mar 2006
QLT Updates on the U.S. Eligard(R) Patent Litigation
Biopharmaceuticals Litigation
 HSMN NewsFeed - 6 Mar 2006
Study Compares Once-daily Metronidazole 1% Gel to Twice-daily Azelaic Acid 15% Gel in the Treatment of Rosacea
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 1 Mar 2006
Genaera Announces Interim EVIZON(TM) Phase II (MSI-1256F-209) Data
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 28 Feb 2006
Genentech Granted Six-Month Priority Review for Lucentis for the Treatment of Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 27 Feb 2006
QLT intends to appeal U.S. Eligard injunction
Biopharmaceuticals Litigation
 HSMN NewsFeed - 27 Feb 2006
QLT's Board of Directors Appoints Robert Butchofsky as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Feb 2006
DUSA Pharmaceuticals Reports Statistically Significant Results from Phase II Clinical Trial for PDT of Photodamaged Skin
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 14 Feb 2006
QLT Announces Preliminary Findings From Phase II Clinical Trial Of Lemuteporfin-injectable In BPH
Biopharmaceuticals Urology
 HSMN NewsFeed - 2 Feb 2006
European Commission Approves Macugen for Treatment of All Types of Wet Age-Related Macular Degeneration; First Treatment to Target Underlying Disease Process of Wet AMD
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 2 Feb 2006
Diomed Launches Next Generation EVLT(R) Procedure Kit
Devices Interventional
 HSMN NewsFeed - 1 Feb 2006
Dusa Pharmaceuticals Reports Results from Phase II Clinical Trial for PDT of Moderate to Severe Acne
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 23 Jan 2006
DUSA Pharmaceuticals Sues Additional Physicians For Infringement Of Its Levulan'R' Photodynamic Therapy Patents
Biopharmaceuticals Licensing Litigation
 HSMN NewsFeed - 18 Jan 2006
DUSA Pharmaceuticals Announces Exclusive Agreement With Stiefel Laboratories To Market Dusa's Levulan'R' Kerastick'R' For Photodynamic Therapy In Latin America
Biopharmaceuticals Dermatology Distribution
 HSMN NewsFeed - 14 Jan 2006
Preliminary Phase III Data from Head-To-Head Study of Lucentis Shows Lucentis Improved Vision Compared to Visudyne in Patients with Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 3 Jan 2006
DUSA Pharmaceuticals Signs Merger Agreement To Acquire Sirius Laboratories
Biopharmaceuticals Mergers & Acquisitions Dermatology
Return to NewsFeed  

 Additional items found! 127

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 127 additional stories matching:
photodynamic therapy
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.